机构：[a]Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China[b]Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China[c]Department of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China[d]Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China[e]Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA[f]Case VA Center for Antimicrobial Resistance and Epidemiology (CARES), Case Western Reserve University, Cleveland, Ohio, USA[g]Research Service, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA[h]Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA[i]Public Health Research Institute Tuberculosis Center, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA[j]Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York, USA[k]Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA[l]Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA
This work was supported in part by grants from the National Institutes of Health
(R01AI090155, R21AI135250, R21AI117338, and CA008748), the Key Research and Development
Project of Jiangsu Provincial Science and Technology Department
(BE2017654), the Six Talent Peaks project in Jiangsu Province (2016-WSN-112), Gusu Key
Health Talent of Suzhou, Jiangsu, Youth Medical Talents program (QN-867), the Science
and Technology Program of Suzhou (SZS201715), and the National Institute of Allergy
and Infectious Diseases of the National Institutes of Health under award numbers
R21AI114508 (R.A.B.), R01AI100560 (R.A.B.), R01AI063517 (R.A.B.), and R01AI072219
(R.A.B.).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2017]版：
大类|2 区医学
小类|2 区微生物学2 区药学
最新[2025]版：
大类|2 区医学
小类|2 区微生物学2 区药学
第一作者：
第一作者机构：[a]Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China[b]Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
共同第一作者：
通讯作者：
通讯机构：[i]Public Health Research Institute Tuberculosis Center, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA
推荐引用方式(GB/T 7714)：
Fangyou Yu ,Jingnan Lv ,Siqiang Niu ,et al.In Vitro Activity of Ceftazidime-Avibactam against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates.[J].Antimicrobial agents and chemotherapy.2018,62(8):doi:10.1128/AAC.01031-18.
APA：
Fangyou Yu,,Jingnan Lv,,Siqiang Niu,,Hong Du,,Yi-Wei Tang,...&Liang Chen.(2018).In Vitro Activity of Ceftazidime-Avibactam against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates..Antimicrobial agents and chemotherapy,62,(8)
MLA：
Fangyou Yu,,et al."In Vitro Activity of Ceftazidime-Avibactam against Carbapenem-Resistant and Hypervirulent Klebsiella pneumoniae Isolates.".Antimicrobial agents and chemotherapy 62..8(2018)
医学